Finzati - Logo
ZBH logo

Zimmer Biomet Holdings, Inc.

ZBHMedical - Devices
$98.07
-0.85 (-0.86%)
Current price
EarningsLatest report: Mar 31, 2026
FAVORABLE PROFILEAttractiveConfidence: 70%

Quantitative profile — not an investment recommendation.

Quantitative profile — not an investment recommendation.Methodology
Analysis thesis: Strong business quality with supportive growth and cash-flow evidence. Valuation still matters, but the historical ratio profile is favorable.
Market Cap
$17.52B
Growth
8.6%
Cash Flow
5/5
Trend
Stable
Evidence
Stable or improving margins · 8.6%Positive revenue growth · 6.2%Positive free cash flow · 7.44Consistent free cash flow · 5/5Manageable debt level · 0.59
Financial data as of: Mar 31, 2026, 12:00 AM UTCLast earnings update: Apr 28, 2026, 12:00 AM UTCLast profile update: Aug 5, 2026, 2:36 PM UTC

Company Snapshot

Key valuation, quality, financial strength, momentum and analyst data.

Price$98.07
Change-0.86%
Market Cap$17.52B
52W Range79.12 - 108.29
Beta0.47
Gross Margin61.62%
Oper. Margin16.55%
Profit Margin8.57%
Debt/Eq0.59
Current Ratio1.98
Quick Ratio1.10
Revenue 5Y8.63%

Investment DNA

How strong this company looks for long-term investors

78
out of 100
Business Quality
Margins, moat, returns
71/100
Financial Strength
Debt, cash, stability
76/100
Growth Potential
Revenue and expansion
68/100
Price Attractiveness
Cheap or expensive today
78/100
Why this score
Stable or improving margins · 8.6%Positive revenue growth · 6.2%Positive free cash flow · 7.44Consistent free cash flow · 5/5Manageable debt level · 0.59Healthy liquidity · 1.98

Analyst view

Analyst sentiment and price target

Analyst sentiment
No vote count available
Bullish
0
Hold
0
Bearish
0
Price Target
2026-06-25
Low
$83.00
Mean
$96.33
Median
$93.00
High
$120.00

Company Overview

IPO: 7/25/2001
Industry: Medical - Devices
P/B i: 1.40
Debt / Equity i: 0.59
Operating Margin: 16.55%
Net Margin: 8.57%
ROE i: -
ROIC: -

Financial Health

Score15 / 20
Debt / Equity: 0.59
Current Ratio: 1.98
Quick Ratio: 1.10
Status: Good

Insider Transactions

Recent executive and insider activity

Yi Sang
Transaction: 05/29/2026
SELL
Change
-800
Price
$82.66
Filing
06/02/2026
Type
SELL
HAGEMANN ROBERT
Transaction: 05/22/2026
BUY
Change
Price
Not reported
Filing
05/27/2026
Type
BUY
HAGEMANN ROBERT
Transaction: 05/22/2026
BUY
Change
Price
$85.68
Filing
05/27/2026
Type
BUY